REG - Integrated Diag Hdgs - IDH's proposed revised Delisting Buyback Price

Integrated Diagnostics HoldingsAnnouncement

27/06/2024 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240627:nRSa0638Ua&default-theme=true

RNS Number : 0638U  Integrated Diagnostics Holdings PLC  27 June 2024

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR
FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE
RELEVANT LAWS OF SUCH JURISDICTION.

 

THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND IS NOT AN OFFER OF
SECURITIES IN ANY JURISDICTION.

 

IDH's proposed revised Delisting Buyback Price in connection with delisting
from the Egyptian Exchange

 

27 June 2024

 

On 24 May 2024, Integrated Diagnostics Holdings Plc ("IDH" or the "Company")
published a Notice of the Extraordinary General Meeting (the "EGM") to be held
on 12 June 2024 in connection with the proposed voluntary delisting of its
ordinary shares (the "Shares") from the Egyptian Exchange (the "EGX").  As
announced on 12 June 2024, all the resolutions contained in the Notice of EGM
were duly passed at the EGM.

 

These resolutions included a resolution authorising the Company to repurchase
Shares from shareholders who hold Shares traded on the EGX held by Misr for
Central Clearing, Depository and Registry ("EGX Shares", and such
shareholders, "EGX Shareholders"), as well as any creditor who has the benefit
of a mortgage over any EGX Shares ("Mortgaged Creditors"), if so required by
such EGX Shareholders or Mortgaged Creditors during the relevant buyback
period which will be specified by the Company (such persons, the "Selling
Shareholders" and such EGX Shares acquired by the Company from the Selling
Shareholders, the "Delisting Sale Shares"). This approach is consistent with
applicable Egyptian regulations and practice for Egyptian-incorporated
companies seeking to delist from the EGX.  Based on the foregoing, it was
determined that the price to be paid by the Company to the Selling
Shareholders (the "Delisting Buyback Price") would be 18.62 Egyptian pounds
per Delisting Sale Share (exclusive of expenses).

 

The Company has since been informed by the EGX that the calculation of the
Delisting Buyback Price did not in fact properly take account of certain
aspects of the applicable regulations given the low trading volumes in the
Company's Shares and, as a consequence, and notwithstanding that the relevant
resolutions have been passed by its shareholders, the Delisting Buyback Price
should instead be 20 Egyptian pounds per Delisting Sale Share (exclusive of
expenses) in accordance with the method of calculating the delisting buyback
price of shares applicable by the EGX.

 

As such, the Company will in the coming days publish a further notice of
extraordinary general meeting to convene another extraordinary general meeting
of shareholders to approve the resolutions required in order to give effect to
the repurchase of Delisting Sale Shares at this revised Delisting Buyback
Price of 20 Egyptian pounds per Delisting Sale Share (exclusive of
expenses).  A further announcement will be made upon the publication of this
further notice of extraordinary general meeting.

 

A summary of the resolutions passed by the board of directors of the Company
in relation to this further extraordinary general meeting is set out in the
Appendix to this announcement.

 

The information contained in this announcement is deemed by the Company to
constitute inside information as stipulated under the UK version of the Market
Abuse Regulation (EU) No. 596/2014 as it forms part of UK law by virtue of the
European Union (Withdrawal) Act 2018.  Upon the publication of this
announcement, this inside information is now considered to be in the public
domain.  Company Matters, IDH's Company Secretary, is responsible for the
release of this announcement for the purposes of such regulation.

 

For further information please contact:

 

Integrated Diagnostics Holdings plc

Tarek Yehia

Investor Relations Director

T: +20 (0)2 3332 1126 | M: +20 10 6882 6678 |  tarek.yehia@idhcorp.com
(mailto:tarek.yehia@idhcorp.com)

 

Company Secretary

Company Matters

IDHLondon@linkgroup.co.uk (mailto:IDHLondon@linkgroup.co.uk)

 

-Ends-

 

About Integrated Diagnostics Holdings (IDH)

 

IDH is a leading diagnostics services provider in the Middle East and Africa
offering a broad range of clinical pathology and radiology tests to patients
in Egypt, Jordan, Nigeria, Sudan and Saudi Arabia.  The Group's core
brands include Al Borg, Al Borg Scan and Al Mokhtabar in Egypt, as well as
Biolab (Jordan), Echo-Lab (Nigeria), Ultralab and Al Mokhtabar Sudan (both
in Sudan ), and Biolab KSA (Saudi Arabia).  With over 40 years of
experience, a long track record for quality and safety has earned the Company
a trusted reputation, as well as internationally recognised accreditations for
its portfolio of over 3 ,000 diagnostics tests.  From its base
of 601 branches as of 31 December 2023 , IDH served over 8. 5 million
patients and performed more than 36.1 million tests in 2023.  IDH will
continue to add laboratories through a Hub, Spoke and Spike business model
that provides a scalable platform for efficient expansion.  Beyond organic
growth, the Group targets expansion in appealing markets,
including acquisitions in the Middle Eastern, African, and East Asian
markets where its model is well-suited to capitalise on similar healthcare and
consumer trends and capture a significant share of fragmented markets.  IDH
has been a Jersey-registered entity with a Standard Listing on the Main Market
of the London Stock Exchange (ticker: IDHC) since May 2015 with a secondary
listing on the EGX since May 2021 (ticker: IDHC.CA).

 

Learn more at  idhcorp.com (http://idhcorp.com/) .

 

Important disclaimers (including in relation to securities law restrictions)

 

This announcement is for information purposes only and is not intended to and
does not constitute or form part of an investment recommendation or any offer
to buy or sell or subscribe for or any invitation to buy, sell or subscribe
for any securities or the solicitation of any vote or approval in any
jurisdiction.

 

 This announcement may contain certain forward-looking statements. A
forward-looking statement is any statement that does not relate to historical
facts and events, and can be identified by the use of such words and phrases
as "according to estimates", "aims", "anticipates", "assumes", "believes",
"could", "estimates", "expects", "forecasts", "intends", "is of the opinion",
"may", "plans", "potential", "predicts", "projects", "should", "to the
knowledge of", "will", "would" or, in each case their negatives or other
similar expressions, which are intended to identify a statement as
forward-looking. This applies, in particular, to statements containing
information on future financial results, plans, or expectations regarding
business and management, future growth or profitability and general economic
and regulatory conditions and other matters affecting the Company and its
subsidiaries (the "Group").

 

Forward-looking statements reflect the current views of the Group's management
("Management") on future events, which are based on the assumptions of the
Management and involve known and unknown risks, uncertainties and other
factors that may cause the Group's actual results, performance or achievements
to be materially different from any future results, performance or
achievements expressed or implied by these forward-looking statements.  The
occurrence or non-occurrence of an assumption could cause the Group's actual
financial condition and results of operations to differ materially from, or
fail to meet expectations expressed or implied by, such forward-looking
statements.

 

The Group's business is subject to a number of risks and uncertainties that
could also cause a forward-looking statement, estimate or prediction to differ
materially from those expressed or implied by the forward-looking statements
contained in this announcement.  The information, opinions and
forward-looking statements contained in this announcement speak only as at its
date and are subject to change without notice.  Save as required by
applicable law, the Group does not undertake any obligation to review, update,
confirm or to release publicly any revisions to any forward-looking statements
to reflect events that occur or circumstances that arise in relation to the
content of this announcement.

 

Appendix - Summary of Board Resolutions

 Minutes of the Board of Directors Meeting held on 26/6/2024 of Integrated        محضر اجتماع مجلس الإدارة المنعقد بتاريخ
 Diagnostics Holdings PLC in accordance with the Companies (Jersey) Law 1991 as   26/6/2024
 amended (the "Law")

                                                                                  لشركة انتجريتيد دياجنوستكس هولدينجز بي ال
                                                                                  سي

                                                                                  طبقا لأحكام قانون شركات جيرسي لسنة 1991
                                                                                  وتعديلاته ("القانون")
 On Wednesday 26 June 2024 at 7:30 PM Cairo Time, the Board of Directors of       انه في يوم الاربعاء الموافق 26 يونيو 2024 في
 Integrated Diagnostics Holdings PLC (the "Company") established under the Law,   تمام الساعة 7:30 مساءاً بتوقيت القاهرة،
 registered with the Jersey Companies Register under no. 117257, with an issued   اجتمع مجلس إدارة شركة انتجريتيد
 capital amounting to (150,000,000 United State dollars) is held via video        دياجنوستكس هولدينجز بي ال سي ("الشركة")
 conference, based on the invitation issued by the Chairman.                      خاضعة لأحكام القانون، ومقيدة بسجل شركات
                                                                                  جيرسي تحت رقم 117257، برأسمال مصدر وقدرة
                                                                                  (150,000,000 دولار أمريكي) وذلك عن طريق وسائل
                                                                                  الاتصال الحديثة (الفيديو كونفرنس)، بناء
                                                                                  على الدعوة الموجهة من السيد رئيس مجلس
                                                                                  الإدارة.
 The meeting was attended by the following Board of Directors' members:           وقد حضر الاجتماع السادة/ أعضاء مجلس
                                                                                  الإدارة التالي أسماؤهم:
 Chairman           Lord Anthony Tudor St. John                                   اللورد/ أنتونى تودور سانت جون                                           رئيس مجلس إدارة
 Managing Director  Prof. Dr. Hend Mohamed Moataz Mostafa Kamel El Sherbini       أ. د / هند محمد معتز مصطفى كامل الشربينى                                العضو المنتدب
 Board Member       Mr. Hussien Hassan Choucri                                    السيد/ حسين حسن شكرى                                                    عضو مجلس إدارة
 Board Member       Mr. Dan Johan Filmar Olsson                                   السيد/ دان يوهان فيلمار أولسون                                          عضو مجلس إدارة
 Board Member       Mr. Richard Henry Phillips                                    السيد/ ريتشارد هينرى فيليبس                                             عضو مجلس إدارة
 Board Member       Mrs. Yvonne Stillhart                                         السيدة/ إيفون ستيلهارت                                                  عضو مجلس إدارة
 Board Member       Mr. Sherif El Zeiny                                           السيد/ شريف الزينى                                                      عضو مجلس إدارة
 The meeting was chaired by Mr. Lord Anthony Tudor St. John (the "Chairman")      وراس الاجتماع اللورد/ أنتونى تودور سانت
 who welcomed the attendees and appointed Ms. Nadira Hussein, representing        جون ("رئيس مجلس الإدارة") وقام رئيس الاجتماع
 Company Matters, as the secretary of the meeting and the Board has approved      بالترحيب بالسادة الحضور ورشح تعيين السيدة/
 such appointment.  The Chairman noted that all directors had previously          ناديرا حسين، ممثلا لقطاع شئون الشركة،
 disclosed their interests and were entitled to attend and vote at the meeting    للقيام بأعمال أمانة سر الاجتماع ووافق
 pursuant to the law and the Company's articles of association having done so.    المجلس على هذا التعيين.

                                                                                  وقد افاد رئيس مجلس الإدارة ان جميع الأعضاء
                                                                                  قد أفصحوا عن عدم وجود تعارض مصالح ووفقا
                                                                                  للقانون والنظام الأساسي للشركة يحق لهم
                                                                                  الحضور والتصويت على القرارات بالاجتماع.
 After deliberating and discussing the meeting's agenda, the Board of Directors   وبعد المداولة والمناقشة في جدول الاعمال
 (Board) present at the meeting have unanimously approved the following           فقد قرر أعضاء المجلس الحاضرين الموافقة
 resolutions:                                                                     بالإجماع على القرارات التالية:
 Resolution No. 1                                                                 القرار الأول
 Further to the resolutions of the Board of Directors meeting held on 15 May      بالإشارة الى قرارات اجتماع مجلس الإدارة
 2024 and the Extraordinary General Assembly Meeting held on 12 June 2024         المنعقد بتاريخ 15 مايو 2024 والجمعية العامة
 resolving to voluntarily delist the Company's shares from the Egyptian Stock     غير العادية للشركة المنعقدة بتاريخ 12 يونيو
 Exchange (the "EGX") and determining the delisting buyback price (the            2024 بالموافقة على شطب أسهم الشركة اختياريا
 "Delisting Buyback Price") at 18.62 Egyptian pounds per share.                   من البورصة المصرية وتحديد سعر شراء أسهم

                                                                                الشطب ("سعر شراء أسهم الشطب") بمبلغ 18.62 جنيه
 The Company has been informed by the EGX that the calculation of the Delisting   مصري للسهم الواحد.
 Buyback Price did not properly take account of certain aspects of the

 applicable regulations given the low trading volumes in the Company's shares     وحيث أن البورصة المصرية قد أبلغت الشركة
 and, as a consequence, and notwithstanding that the relevant resolutions have    بأن طريقة حساب سعر أسهم الشطب لا يتوافق مع
 been passed by its shareholders, the Delisting Buyback Price should instead be   اللوائح المعمول بها نظرًا لانخفاض أحجام
 20 Egyptian pounds per share (exclusive of expenses) in accordance with the      التداول على أسهم الشركة، ونتيجة لذلك، وعلى
 method of calculating the delisting buyback price of shares applicable by the    الرغم من القرارات ذات الصلة التي تم
 Egyptian stock exchange.                                                         اعتمادها من قبل المساهمين، يجب أن يكون سعر

                                                                                شراء أسهم الشطب 20 جنيه مصري للسهم الواحد
                                                                                  (غير شامل للنفقات) وذلك وفقا لطريقة احتساب

                                                                                سعر أسهم الشطب المعمول بها بالبورصة
 Based on the foregoing, the Board of Directors have unanimously approved: i)     المصرية.
 the convening of an Extraordinary General Meeting (EGM) of the Company's

 shareholders to approve the buyback at the revised Delisting Buyback Price of    وبناءاً عليه، وافق مجلس الإدارة بالأجماع
 20 Egyptian pounds instead of 18.62 Egyptian pounds per Delisting Sale Share     على تقديم مقترح للجمعية العامة غير العادية
 (exclusive of expenses) and the holding in treasury of such repurchased          لتعديل سعر شراء أسهم الشطب ليصبح 20 جنيه
 Delisting Sale Shares, ii) the announcement of the revised Delisting Buyback     مصري بدلا من 18.62 جنيه مصري للسهم الواحد (غير
 Price to be released to the London Stock Exchange at 7:00 am BST on Thursday     شامل للنفقات) وذلك في ضوء ما سبق بيانه.
 27(th) June 2024, and at the same time, to the EGX, iii) the delegation of

 authority to any two Board Members to approve the final EGM circular and         وبناء على ما تقدم فقد وافق مجلس الإدارة
 notice, and iv) the buyback at the revised Delisting Buyback Price and the       بالإجماع على ما يلي:
 holding in treasury of such repurchased Delisting Sale Shares.

                                                                                  (أ) عقد جمعية عامة غير عادية لمساهمي الشركة
                                                                                  للموافقة على شراء أسهم الشطب بسعر الشراء
                                                                                  المعدل البالغ 20 جنيهًا مصريًا بدلاً من 18.62
                                                                                  جنيهًا مصريًا للسهم الواحد (غير شامل
                                                                                  للنفقات) والاحتفاظ بتلك الأسهم كأسهم
                                                                                  خزينة،

                                                                                   (ب) الإعلان عن سعر شراء أسهم الشطب المعدل
                                                                                  في بورصة لندن في الساعة 7:00 صباحًا بتوقيت
                                                                                  جرينتش يوم الخميس 27 يونيو 2024، وفي نفس الوقت
                                                                                  في البورصة المصرية،

                                                                                  (ج) تفويض اثنين من أعضاء مجلس الإدارة
                                                                                  للموافقة على دعوة الجمعية العامة غير
                                                                                  العادية في صيغتها النهائية، و

                                                                                  (د) شراء أسهم الشطب بسعر الشراء المعدل
                                                                                  والاحتفاظ بتلك الأسهم كأسهم خزينة.
 Resolution No. 2                                                                 القرار الثاني
 The attendees have unanimously approved to delegate Prof. Dr. Hend Mohamed       وافق الحضور بالإجماع على تفويض أ. د / هند
 Moataz Mostafa Kamel El Sherbini or any person who is authorized by the Board,   محمد معتز مصطفى كامل الشربيني او من يفوضه
 solely, in taking all necessary procedures to voluntarily delist the Company's   المجلس منفردين في اتخاذ كافة الإجراءات
 shares from the Egyptian Exchange and purchase the shares of the affected        اللازمة لشطب قيد اسهم الشركة من البورصة
 shareholders and/or those objecting to the voluntary delisting and/or            المصرية شطبا اختياريا وشراء اسهم
 mortgaged creditors and revising the Delisting Buyback Price. In this respect,   المساهمين المتضررين و/او المعترضين على
 such persons shall have all the powers and authorities to represent the          الشطب و/او الدائنين المرتهنين وتعديل سعر
 Company before all governmental and non-governmental entities, the Egyptian      شراء أسهم الشطب ولهم في ذلك كافة السلطات
 Exchange, the Financial Regulatory Authority and the Misr for Central            والصلاحيات في تمثيل الشركة امام كافة
 Clearing, Depository and Registry and have been authorized severally to take     الجهات الحكومية وغير الحكومية والبورصة
 all procedures in relation to the publication of any announcements or            المصرية و الهيئة العامة للرقابة المالية
 disclosures concerning the implementation of the delisting procedures. Such      وشركة مصر للمقاصة والايداع والحفظ المركزي
 persons shall have the right to entirely or partially delegate the               وتفويضهم منفردين في اتخاذ كافة الإجراءات
 aforementioned to third parties.                                                 المتعلقة بنشر أي إعلانات او افصاحات خاصة
                                                                                  بتنفيذ إجراءات الشطب ولهم الحق في تفويض او
                                                                                  توكيل الغير في كل او بعض ما سبق.
 Resolution No. 3                                                                 القرار الثالث
 The attendees have unanimously approved inviting the Extraordinary General       وافق الحضور بالإجماع على دعوة الجمعية
 Meeting of the Company to resolve, in connection with the delisting of the       العامة غير العادية للشركة للنظر في تعديل
 Company's shares which are listed on the Egyptian Exchange, to allow the         سعر شراء أسهم الشطب في ضوء شطب أسهم الشركة
 buyback of shares on the EGX including the amendment of the Delisting Buyback    اختياريا من البورصة المصرية بما في ذلك
 Price and the holding of such shares in treasury and authorized the Chairman     تعديل سعر شراء أسهم الشطب والاحتفاظ بها
 in serving the invitations of the Extraordinary General Meeting and              كأسهم خزينة وتفويض رئيس مجلس الإدارة في
 determining the agenda, place and time of convening the same.                    توجيه دعوة الجمعية العامة غير العادية
                                                                                  للشركة وتحديد بنود جدول الاعمال وموعد
                                                                                  ومكان الانعقاد.

 At 8:00 PM Cairo Time, the meeting ended after the Chairman has thanked the      وحيث كانت الساعة 8:00 مساءاً بالتوقيت
 attendees.                                                                       المحلى، انتهى الاجتماع بعد ان قام السيد/
                                                                                  رئيس الاجتماع بتوجيه الشكر للسادة الحضور.

 اللورد/ أنتونى تودور سانت جون                                           رئيس مجلس إدارة
 أ. د / هند محمد معتز مصطفى كامل الشربينى                                العضو المنتدب
 السيد/ حسين حسن شكرى                                                    عضو مجلس إدارة
 السيد/ دان يوهان فيلمار أولسون                                          عضو مجلس إدارة
 السيد/ ريتشارد هينرى فيليبس                                             عضو مجلس إدارة
 السيدة/ إيفون ستيلهارت                                                  عضو مجلس إدارة
 السيد/ شريف الزينى                                                      عضو مجلس إدارة

The meeting was chaired by Mr. Lord Anthony Tudor St. John (the "Chairman")
who welcomed the attendees and appointed Ms. Nadira Hussein, representing
Company Matters, as the secretary of the meeting and the Board has approved
such appointment.  The Chairman noted that all directors had previously
disclosed their interests and were entitled to attend and vote at the meeting
pursuant to the law and the Company's articles of association having done so.

وراس الاجتماع اللورد/ أنتونى تودور سانت
جون ("رئيس مجلس الإدارة") وقام رئيس الاجتماع
بالترحيب بالسادة الحضور ورشح تعيين السيدة/
ناديرا حسين، ممثلا لقطاع شئون الشركة،
للقيام بأعمال أمانة سر الاجتماع ووافق
المجلس على هذا التعيين.

وقد افاد رئيس مجلس الإدارة ان جميع الأعضاء
قد أفصحوا عن عدم وجود تعارض مصالح ووفقا
للقانون والنظام الأساسي للشركة يحق لهم
الحضور والتصويت على القرارات بالاجتماع.

After deliberating and discussing the meeting's agenda, the Board of Directors
(Board) present at the meeting have unanimously approved the following
resolutions:

وبعد المداولة والمناقشة في جدول الاعمال
فقد قرر أعضاء المجلس الحاضرين الموافقة
بالإجماع على القرارات التالية:

Resolution No. 1

القرار الأول

Further to the resolutions of the Board of Directors meeting held on 15 May
2024 and the Extraordinary General Assembly Meeting held on 12 June 2024
resolving to voluntarily delist the Company's shares from the Egyptian Stock
Exchange (the "EGX") and determining the delisting buyback price (the
"Delisting Buyback Price") at 18.62 Egyptian pounds per share.

The Company has been informed by the EGX that the calculation of the Delisting
Buyback Price did not properly take account of certain aspects of the
applicable regulations given the low trading volumes in the Company's shares
and, as a consequence, and notwithstanding that the relevant resolutions have
been passed by its shareholders, the Delisting Buyback Price should instead be
20 Egyptian pounds per share (exclusive of expenses) in accordance with the
method of calculating the delisting buyback price of shares applicable by the
Egyptian stock exchange.

 

Based on the foregoing, the Board of Directors have unanimously approved: i)
the convening of an Extraordinary General Meeting (EGM) of the Company's
shareholders to approve the buyback at the revised Delisting Buyback Price of
20 Egyptian pounds instead of 18.62 Egyptian pounds per Delisting Sale Share
(exclusive of expenses) and the holding in treasury of such repurchased
Delisting Sale Shares, ii) the announcement of the revised Delisting Buyback
Price to be released to the London Stock Exchange at 7:00 am BST on Thursday
27(th) June 2024, and at the same time, to the EGX, iii) the delegation of
authority to any two Board Members to approve the final EGM circular and
notice, and iv) the buyback at the revised Delisting Buyback Price and the
holding in treasury of such repurchased Delisting Sale Shares.

بالإشارة الى قرارات اجتماع مجلس الإدارة
المنعقد بتاريخ 15 مايو 2024 والجمعية العامة
غير العادية للشركة المنعقدة بتاريخ 12 يونيو
2024 بالموافقة على شطب أسهم الشركة اختياريا
من البورصة المصرية وتحديد سعر شراء أسهم
الشطب ("سعر شراء أسهم الشطب") بمبلغ 18.62 جنيه
مصري للسهم الواحد.

وحيث أن البورصة المصرية قد أبلغت الشركة
بأن طريقة حساب سعر أسهم الشطب لا يتوافق مع
اللوائح المعمول بها نظرًا لانخفاض أحجام
التداول على أسهم الشركة، ونتيجة لذلك، وعلى
الرغم من القرارات ذات الصلة التي تم
اعتمادها من قبل المساهمين، يجب أن يكون سعر
شراء أسهم الشطب 20 جنيه مصري للسهم الواحد
(غير شامل للنفقات) وذلك وفقا لطريقة احتساب
سعر أسهم الشطب المعمول بها بالبورصة
المصرية.

وبناءاً عليه، وافق مجلس الإدارة بالأجماع
على تقديم مقترح للجمعية العامة غير العادية
لتعديل سعر شراء أسهم الشطب ليصبح 20 جنيه
مصري بدلا من 18.62 جنيه مصري للسهم الواحد (غير
شامل للنفقات) وذلك في ضوء ما سبق بيانه.

وبناء على ما تقدم فقد وافق مجلس الإدارة
بالإجماع على ما يلي:

(أ) عقد جمعية عامة غير عادية لمساهمي الشركة
للموافقة على شراء أسهم الشطب بسعر الشراء
المعدل البالغ 20 جنيهًا مصريًا بدلاً من 18.62
جنيهًا مصريًا للسهم الواحد (غير شامل
للنفقات) والاحتفاظ بتلك الأسهم كأسهم
خزينة،

 (ب) الإعلان عن سعر شراء أسهم الشطب المعدل
في بورصة لندن في الساعة 7:00 صباحًا بتوقيت
جرينتش يوم الخميس 27 يونيو 2024، وفي نفس الوقت
في البورصة المصرية،

(ج) تفويض اثنين من أعضاء مجلس الإدارة
للموافقة على دعوة الجمعية العامة غير
العادية في صيغتها النهائية، و

(د) شراء أسهم الشطب بسعر الشراء المعدل
والاحتفاظ بتلك الأسهم كأسهم خزينة.

Resolution No. 2

القرار الثاني

The attendees have unanimously approved to delegate Prof. Dr. Hend Mohamed
Moataz Mostafa Kamel El Sherbini or any person who is authorized by the Board,
solely, in taking all necessary procedures to voluntarily delist the Company's
shares from the Egyptian Exchange and purchase the shares of the affected
shareholders and/or those objecting to the voluntary delisting and/or
mortgaged creditors and revising the Delisting Buyback Price. In this respect,
such persons shall have all the powers and authorities to represent the
Company before all governmental and non-governmental entities, the Egyptian
Exchange, the Financial Regulatory Authority and the Misr for Central
Clearing, Depository and Registry and have been authorized severally to take
all procedures in relation to the publication of any announcements or
disclosures concerning the implementation of the delisting procedures. Such
persons shall have the right to entirely or partially delegate the
aforementioned to third parties.

وافق الحضور بالإجماع على تفويض أ. د / هند
محمد معتز مصطفى كامل الشربيني او من يفوضه
المجلس منفردين في اتخاذ كافة الإجراءات
اللازمة لشطب قيد اسهم الشركة من البورصة
المصرية شطبا اختياريا وشراء اسهم
المساهمين المتضررين و/او المعترضين على
الشطب و/او الدائنين المرتهنين وتعديل سعر
شراء أسهم الشطب ولهم في ذلك كافة السلطات
والصلاحيات في تمثيل الشركة امام كافة
الجهات الحكومية وغير الحكومية والبورصة
المصرية و الهيئة العامة للرقابة المالية
وشركة مصر للمقاصة والايداع والحفظ المركزي
وتفويضهم منفردين في اتخاذ كافة الإجراءات
المتعلقة بنشر أي إعلانات او افصاحات خاصة
بتنفيذ إجراءات الشطب ولهم الحق في تفويض او
توكيل الغير في كل او بعض ما سبق.

Resolution No. 3

القرار الثالث

The attendees have unanimously approved inviting the Extraordinary General
Meeting of the Company to resolve, in connection with the delisting of the
Company's shares which are listed on the Egyptian Exchange, to allow the
buyback of shares on the EGX including the amendment of the Delisting Buyback
Price and the holding of such shares in treasury and authorized the Chairman
in serving the invitations of the Extraordinary General Meeting and
determining the agenda, place and time of convening the same.

وافق الحضور بالإجماع على دعوة الجمعية
العامة غير العادية للشركة للنظر في تعديل
سعر شراء أسهم الشطب في ضوء شطب أسهم الشركة
اختياريا من البورصة المصرية بما في ذلك
تعديل سعر شراء أسهم الشطب والاحتفاظ بها
كأسهم خزينة وتفويض رئيس مجلس الإدارة في
توجيه دعوة الجمعية العامة غير العادية
للشركة وتحديد بنود جدول الاعمال وموعد
ومكان الانعقاد.

 

At 8:00 PM Cairo Time, the meeting ended after the Chairman has thanked the
attendees.

وحيث كانت الساعة 8:00 مساءاً بالتوقيت
المحلى، انتهى الاجتماع بعد ان قام السيد/
رئيس الاجتماع بتوجيه الشكر للسادة الحضور.

 

Chairman:   Lord Anthony Tudor St. John

Secretary of the Board:   Company Matters

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCDXGDLDGDDGSL